✦ LIBER ✦

Current status of glucosamine therapy in osteoarthritis

✍ Scribed by Towheed, Tanveer E.

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 52 KB
Volume: 49
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.11183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status of phthalocyanines in the

Current status of phthalocyanines in the photodynamic therapy of cancer

✍ Cynthia M. Allen; Wesley M. Sharman; Johan E. Van Lier 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Photodynamic therapy is a binary treatment now accepted in clinic for various malignancies in several countries around the world. Phthalocyanine molecules are second-generation photosensitizers with enhanced photophysical and photochemical properties over those of porphyrins. They have been shown to

A view of the current status of antisick

A view of the current status of antisickling therapy

✍ George J. Brewer 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

## Abstract About 5‐10 years ago it became popular to say that we understood the genetic and molecular basis for sickle cell anemia better than for any other disease and yet had no effective treatment. It was correctly pointed out that very little money was being spent at that time on sickle cell r

ChemInform Abstract: Current Status of t

ChemInform Abstract: Current Status of trans-Platinum Compounds in Cancer Therapy

✍ Giovanni Natile; Mauro Coluccia 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

Current status of thyrotropin-releasing

Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis

📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Amyotrophic lateral sclerosis (ALS) and its variants are feared progressive neurological diseases of which the etiology and pathogenesis are unknown and for which therapy is unavailable. In 1983, Engel and associates 1 11 reported that infusion of thyrotropin-releasing hormone (TRH) improved strengt

131I MIBG therapy in neuroblastoma: Mech

131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status

✍ Tepmongkol, Supatporn; Heyman, Sydney 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

I MIBG has been used as palliative treatment of neuroblastoma patients with recurrent or persistent disease who failed other modalities of treatment. Since the results were promising, the concept arose of using it in conjunction with other modalities, either as an up-front treatment or as combinatio

Current and future status of adjuvant th

Current and future status of adjuvant therapy for breast cancer

✍ Robert E. Coleman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra